Group 1: IPO Highlights - Aktis Oncology led the week with a large IPO, raising $318 million at a valuation of $1 billion, focusing on α-radiopharmaceuticals for solid tumors [1] - Buda Juice completed its IPO at the lower end of its price range, raising $20 million with a market cap of $95 million, emphasizing its "super fresh" juice category [2] - Atlas Critical Minerals also completed its IPO at the lower end, raising $10 million with a market cap of $40 million, focusing on mineral exploration in Brazil [2] Group 2: SPAC Activity - Five SPACs completed their IPOs, including Lafayette Digital Acquisition and Bleichroeder Acquisition II, each raising $250 million, targeting financial services and technology sectors [3] - Other SPACs like Art Technology Acquisition and Soren Acquisition raised $220 million and $150 million respectively, focusing on technology and healthcare [3] Group 3: Upcoming IPO Filings - Six companies filed for IPOs, including Brazilian digital bank PicS seeking $500 million and discount furniture retailer Bobs Discount Furniture aiming for $400 million [5] - Other notable filings include Forgent Power Solutions for $200 million and Eikon Therapeutics for $100 million, both in the healthcare sector [5] Group 4: Market Outlook - The IPO market is expected to be quiet in the upcoming week after the recent large IPO, with smaller issuers potentially joining the market [6] - Several large companies that have submitted IPO applications remain eligible to go public soon, including EquipmentShare.com and Motive Technologies [7]

Group 1: Elauwit Connection (ELWT) - Elauwit Connection plans to raise $15 million by issuing 1.67 million shares at a price of $9 per share, reflecting the company's valuation and market sentiment towards the broadband sector [2] - The company focuses on multi-family residential broadband services, offering a comprehensive service system that includes network design, project management, installation, and maintenance, which is a key competitive advantage [2] - For the first half of 2025, Elauwit Connection reported revenue of $11.69 million but incurred a net loss of $380,000, which is common for companies in the expansion phase due to high initial investments [3] Group 2: Innocan Pharma - Innocan Pharma, already listed in Canada, aims to raise $15.19 million by issuing 1.09 million shares at a price of $13.962 per share, indicating market confidence in its pharmaceutical business [4] - The company specializes in chronic pain management, focusing on the development and sale of CBD-related drugs, utilizing LPT-CBD technology to enhance drug efficacy [4] - In the first half of 2025, Innocan Pharma achieved revenue of $14.80 million but faced a net loss of $540,000, which is attributed to the high costs associated with drug development and market promotion [5] Group 3: Buda Juice (BUDA) - Buda Juice plans to raise between $20 million and $24 million by issuing 2.67 million shares at a price range of $7.5 to $9 per share, making it the largest fundraising effort among the three companies [6] - The company operates in the juice industry, focusing on citrus beverages and has developed an end-to-end cold chain platform to ensure product freshness, which provides a competitive edge [7] - For the first half of 2025, Buda Juice reported revenue of $6.55 million and achieved a net profit of $1.98 million, making it the only profitable company among the three, showcasing strong cost control and business profitability [7]